CH Biotech R&D Co., Ltd. (TPE:6534)
94.50
+0.50 (0.53%)
Oct 8, 2026, 1:30 PM CST
CH Biotech R&D Market Cap
CH Biotech R&D has a market cap or net worth of 9.53 billion as of October 9, 2026. It is the 18,458th most valuable company in the world and the 758th biggest in Taiwan. Its market cap has decreased by 19.42% in one year.
Market Cap
9.53B
Enterprise Value
9.75B
Revenue
1.87B
Global Rank
Country Rank
#758 Taiwan
PE Ratio
16.08
ChartMarket Cap Chart
Since July 2, 2015, CH Biotech R&D's market cap has increased from 7.47B to 9.53B, an increase of 27.52%. That is a compound annual growth rate of 2.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 9.53B | 2.96% |
| Dec 31, 2025 | 9.25B | 11.39% |
| Dec 31, 2024 | 8.31B | 0.37% |
| Dec 29, 2023 | 8.28B | 13.05% |
| Dec 30, 2022 | 7.32B | 42.15% |
| Dec 30, 2021 | 5.15B | 20.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nan Ya Plastics | 2.49T |
| Formosa Plastics | 479.98B |
| Formosa Chemicals & Fibre | 443.36B |
| China Steel | 288.83B |
| LCY Technology | 10.15B |
| Froch Enterprise | 10.14B |
| Keding Enterprises | 10.09B |
| Taiwan Hopax Chemicals Manufacturing | 9.91B |